Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8809320 Benzodiazepine derivatives

Patent 8809320 was granted and assigned to Immunogen, Inc. on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert Yongxin Zhao0

Nathan Elliott Fishkin0

Ravi V. J. Chari0

Wei Li0

Michael Louis Miller0

Date of Patent

August 19, 2014

0

Patent Application Number

137740590

Date Filed

February 22, 2013

0

Patent Citations Received

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent 11707532 Compositions and methods of treating muscle dystrophy

0

US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof

0

US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

US Patent RE49918 Cytotoxic benzodiazepine derivatives

0

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

0

US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8809320 Benzodiazepine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool